Literature DB >> 2586573

Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy.

D S Burke, R R Redfield, D C Bjornson, A K Fowler, C N Oster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2586573     DOI： 10.1056/NEJM198912143212414

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Zidovudine prophylaxis following exposure to human immunodeficiency virus.

Authors:  R A Miller
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

2.  Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple.

Authors:  M O Salminen; J K Carr; D L Robertson; P Hegerich; D Gotte; C Koch; E Sanders-Buell; F Gao; P M Sharp; B H Hahn; D S Burke; F E McCutchan
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients.

Authors:  M J McElrath; R M Steinman; Z A Cohn
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

4.  Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

Authors:  A J Japour; D L Mayers; V A Johnson; D R Kuritzkes; L A Beckett; J M Arduino; J Lane; R J Black; P S Reichelderfer; R T D'Aquila
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.